CRN’s says that phytosterol-powdered dietary supplements should be exempt from FDA's December 2010 ruling.
FDA’s December 2010 proposed rule for products containing phytosterols states that dietary supplements using free-form phytosterols will not warrant health claims for cholesterol-lowing effects. But the Council for Responsible Nutrition (CRN; Washington, DC) has since responded to FDA, urging that the agency reconsider data used to make its conclusion on free-form phytosterol dietary supplements.
CRN’s belief is that phytosterol-powdered dietary supplements should be exempt from this ruling.
“A free phytosterol powdered dietary supplement that is reconstituted into a food or liquid beverage will overcome dissolution and distribution limitations that may occur with the tablet or capsule form of free phytosterols,” said CRN in a recent press statement.
In reviewing data that FDA originally reviewed to make its claim, CRN observed that studies with free phytosterol powders meeting United States Pharmacopeia (USP) disintegration standards produced cholesterol-lowering results while studies that did not meet the standards did not provide an effect.
CRN is now calling for free-form phytosterol dietary supplements to be allowed a cholesterol health claim assuming the active ingredient meets USP standards for disintegration.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.